Ryan D. Welch
Salk Institute for Biological Studies(US)Blackburn College(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Muscle Physiology and Disorders, Receptor Mechanisms and Signaling, Adipose Tissue and Metabolism, Gut microbiota and health
Most-Cited Works
- → Global chemical effects of the microbiome include new bile-acid conjugations(2020)571 cited
- → The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis(2015)87 cited
- → Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function(2023)56 cited
- → Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle(2017)46 cited
- → Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity(2023)42 cited
- → Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome(2017)39 cited
- → Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice(2021)29 cited
- → Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH(2022)24 cited
- → Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice(2020)10 cited
- → REV-ERB and ROR: therapeutic targets for treating myopathies(2017)9 cited